Premium
P1‐072: PRE‐CLINICAL CHARACTERIZATION OF HUMANIZED, BLOOD‐BRAIN BARRIER (BBB)‐PENETRATING, AMYLOID‐β (Aβ) OLIGOMER‐TARGETING FUSION PROTEIN
Author(s) -
Rennie Kerry,
Atkinson Trevor,
Brown Leslie,
Menard Michel,
Brunette Eric,
Pelletier Alex,
Jiang Susan,
Baumann Ewa,
Delaney Christie,
Grazzini Eric,
Haqqani Arsalan,
Lessard Etienne,
Rosa-Neto Pedro,
Gillard John,
Yoganathan Nathan,
Tiwari Krishnaraj,
Paquette Donald,
Patel Mehul,
Durocher Yves,
Stanimirovic Danica,
Chakravarthy Balu
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.074
Subject(s) - blood–brain barrier , western blot , chemistry , transgene , fusion protein , in vivo , genetically modified mouse , microbiology and biotechnology , blot , pharmacology , recombinant dna , biochemistry , biology , central nervous system , endocrinology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom